Sundial: Analysts Expect Positive EBITDA For Q3 2021

Sundial Growers (NASDAQ: SNDL) announced that they will be reporting their third quarter financials after the markets close on November 10th.

Analysts have a consensus US$0.71 12-month price target on the company, via a total of 5 analysts, with 4 analysts having hold ratings, and one other analyst has a sell rating on the company. The street high comes from ATB Capital Markets with a US$0.80 price target, and the lowest target comes from Cantor Fitzgerald with a US$0.00 price target.

Only 4 analysts have revenue estimates for the third quarter. The mean between all 4 is C$16.48 million; this number has been remained flat since the start of May. The street high is C$19.1 million while the lowest sits at C$11.40 million.

Only two analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 35.3%, with this number being flat at the start of May. Street high is a 40.6% estimate and the lowest sits at 30%.

Onto EBITDA estimates, there are currently only 3 analysts who have third-quarter EBITDA estimates. The mean is currently C$0.97 million, with this number being slightly higher than at the start of May. Street high sits at C$2 million EBITDA and the lowest being a (C$0.4) million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Can the World Actually Supply $6 Copper? | Greg Ferron – PTX Metals

1911 Gold: The Power Of A Mine Restart

Is Gold Repeating the 2005 Setup Before The Big Run? | Geordie Mark

Recommended

Nord Precious Metals Hits Multiple Intervals Of Mineralization In Latest Drill Hole At Castle East

Goliath Resources Sees 13% Grade Boost As Stifel Draws Parallels To Great Bear

Related News

Canadian Cannabis: Canaccord Lifts Cronos Target, Reiterates Canopy Growth And Tilray Ratings

Yesterday Canaccord Genuity Capital Markets put out a second-quarter preview note on the top Canadian...

Thursday, July 28, 2022, 03:02:00 PM

Well Health: PI Financial Raises Price Target To $7.00 On Back Of Circle Acquisition

This week WELL Health Technologies (TSX: WELL) announced that they are expanding into the US...

Friday, September 4, 2020, 01:38:00 PM

PopReach Receives Upgraded Price Target from Canaccord Amid $5M Investment from Alibaba Investment Arm

On Thursday, PopReach (TSXV: POPR) announced a $5.0 million investment from eWTP Tech Innovation Fund...

Sunday, October 18, 2020, 12:48:00 PM

Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused

On August 3, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Wednesday, September 29, 2021, 11:44:00 AM

Sundial Growers To Acquire Alcanna In $346 Million Transaction

Sundial Growers (NASDAQ: SNDL) has taken a page out of the Tilray (NASDAQ: TLRY) playbook...

Friday, October 8, 2021, 08:13:00 AM